Ireland· IE-PA-PA2315/263/001
Orlistat Accord 120 mg hard capsules
A orlistat product containing orlistat, registered in Ireland by Accord Healthcare Ireland Ltd.. The same ATC class is registered in 16 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Orlistat is registered in 16 of 19 countries.
Countries holding a registration under ATC A08AB01 (orlistat), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 9 of them publish a price we can compare per daily dose
Orlistat · ATC A08AB01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of orlistat costs, country by country.
Normalised to the WHO defined daily dose (0.36 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Orlistat · price per daily dose (0.36 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.08
The record
At a glance
HPRA (Ireland)- Active substance
- Orlistat
- Manufacturer
- Accord Healthcare Ireland Ltd.
- Country
- Ireland (IE)
- ATC code
- A08AB01
- ATC class
- Orlistat
- Defined daily dose
- 0.36 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2315/263/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
374 interactions on record for orlistat.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Orlistat · interactions on record
374 records
- 9 severe
- 117 moderate
- 8 minor
- 238 info
Most severe, free to view
- TriheptanoinA16AX17severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- PexidartinibL01EX15severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Orlistat in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainNORMOSTAT 120 MG CAPSULAS DURASLaboratorios Normon S.A.
- United KingdomBeacita 120mg capsulesActavis UK Ltd
- CzechiaORLISTAT SANDOZSandoz s.r.o., Praha
- SwitzerlandOrlistat Sandoz, HartkapselnSandoz Pharmaceuticals AG
- FinlandAlliGlaxo Group Ltd
- SwedenBeacita 120 mg Kapsel, hårdTeva B.V.
- BelgiumOrlistat Sandoz 120 mgSandoz
- NorwayXenicalAbacus Medicine A/S
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Belgium · Orlistat Sandoz, Orlistat Teva
- Czechia · Orlistat 1 A Pharma, Orlistat Sandoz
- Germany · Orlistat 1 A Pharma, Orlistat Hexal
- Denmark · Orlistat Accord, Orlistat Rivopharm
- Estonia · Orlistat Sandoz
- Spain · Beacita, Elimens
- Finland · Orlistat Sandoz, Orlistat Stada
- France · Orlistat Eg
- United Kingdom (Northern Ireland) · Orlistat, Orlistat Accord-Uk
- Iceland · Alli, Xenical
- Italy · Beacita
- Liechtenstein · Alli, Xenical
- Lithuania · Orlistat Polpharma
- Latvia · Orlistat Polpharma
- Netherlands · Orlistat Sandoz
- Norway · Alli, Orlistat Accord
- Portugal · Orlistato Beacita, Orlistato Ciclum
- Sweden · Beacita, Orlistat Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3d291890-7817-4633-9153-3dc68cd72237 GET /v1/drugs/3d291890-7817-4633-9153-3dc68cd72237?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"A08AB01"
],
"strength": null,
"pa_number": "PA2315/263/001",
"substances": [
"Orlistat"
],
"legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "28/07/2023",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about orlistat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.